Microbiology (medical)
686 articles · 16 journals
Journals in this subcategory (16)
- Clinical Epidemiology and Global Health · Elsevier (95)
- International Journal of Infectious Diseases · Elsevier (91)
- Indian Journal of Medical Microbiology · Elsevier (90)
- Journal of Microbiological Methods · Elsevier (86)
- The Lancet Microbe · Elsevier (82)
- International Journal of Medical Microbiology · Elsevier (58)
- Enfermedades Infecciosas y Microbiología Clínica · Elsevier (53)
- Infectious Disease Clinics of North America · Elsevier (33)
- Journal of Infection · Elsevier (29)
- Revista Argentina de Microbiología · Elsevier (26)
- Infectious Medicine · Elsevier (25)
- Tuberculosis · Elsevier (18)
- Current Clinical Microbiology Reports · Springer Nature (0)
- European Journal of Clinical Microbiology & Infectious Diseases · Springer Nature (0)
- Infectious Diseases and Therapy · Springer Nature (0)
- Microbiome · Springer Nature (0)
- Early mortality in mice reflects differential virulence of Mycobacterium bovis and Mycobacterium tuberculosis in C3H/HeJ mice: A pilot study
- Immunogenicity and shedding of live-attenuated intranasal respiratory syncytial virus vaccine in children aged 6–18 months by baseline serostatus: a multicentre, randomised, placebo-controlled, phase 1/2 trial
- Airborne transmission risk of monkeypox virus: the importance of infection-competent virus
- Implementation of rapid pan-microbial metagenomics in paediatric intensive care: a single-centre, prospective, observational study
- Bourbon virus: an expanding tick-borne threat hidden by diagnostic blind spots
- Cholera rapid diagnostic test performance at the host–microbe interface: a prospective longitudinal study in Bangladesh
- Phylogeographical structure and genetic introgression in Salmonella enterica serotype Napoli: a genomic epidemiology study
- Biomarker tests for invasive Candida infection in critically ill patients in the UK (A-Stop): a multicentre diagnostic test accuracy study
- Antibiotic overuse and mortality in patients hospitalised for COVID-19: a global cohort study
- Antimicrobial selection is only part of the story: from resistance to persistence
- Mycobacterium tuberculosis complex strain discordance among people with tuberculosis and a history of household contact: a systematic review and meta-analysis
- US CDC’s 5-day recommendation of the artemether–lumefantrine regimen: lessons from Africa and travellers
- Expanding Epstein–Barr virus-associated disease burden prioritises vaccine development
- Diversity analysis of indoor and outdoor fungal bioaerosols: methodological considerations
- Novel dengue serotype 4 live virus human challenge: a phase 1 dose optimisation and homologous rechallenge study
- Clinical and immunological correlates of CXCR4 coreceptor use in people with HIV-1 receiving antiretroviral therapy in the Netherlands: a multicentre cohort study
- Nigeria responds to Ebola Bundibugyo virus case
- No end to tuberculosis without women and children
- The silence of the alarms: Cyclospora and the fragility of foodborne surveillance
- From reactive to proactive: rethinking parasite controls in the fresh produce chain
- MERS-CoV: time to reassess the case-fatality rate
- Prevalence-adaptive sequential antigen and molecular testing for mpox at the point-of-care
- Collateral sensitivity identified in surveillance data shows limited reproducibility in clinical isolates
- Female genital schistosomiasis in migrant women: diagnostic challenges in non-endemic settings
- Visceral leishmaniasis in Brazil
- Research response to the Bundibugyo ebolavirus outbreak
- Epidemiology and phylogenomic characterisation of the 2025 Ebola virus disease outbreak in Bulape, Kasaï province, Democratic Republic of the Congo: a retrospective observational study
- Profiling the dynamics of maternally acquired and infection-induced antibodies against influenza B in early childhood: a longitudinal paired mother–infant cohort study from southern China
- Non-canonical phage–bacterium interactions during topical phage therapy in the PhagoBurn clinical trial: a retrospective, observational, reverse translational study
- A WHO International Standard for neutralising antibodies to Chikungunya virus: development and evaluation